Market Cap 77.49M
Revenue (ttm) 100,000.00
Net Income (ttm) -33.04M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -33,040.00%
Debt to Equity Ratio 0.00
Volume 184,800
Avg Vol 722,730
Day's Range N/A - N/A
Shares Out 64.31M
Stochastic %K 3%
Beta 1.29
Analysts Strong Sell
Price Target $5.53

Company Profile

iBio, Inc., a preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cardiometabolic and obesity space. The company's technology platforms include EngageTx that provides improved CD3 T-cell engager antibody panel; ShieldTx, an antibody masking technology that enables the creation of conditionally activated antibodies; StableHu, an AI antibody-optimizing technology; and AI epitope steering technology that guides antibodies agai...

Industry: Biotechnology
Sector: Healthcare
Phone: 979 446 0027
Website: ibioinc.com
Address:
11750 Sorrento Valley Road, Suite 200, San Diego, United States
Buddy44444444
Buddy44444444 Sep. 11 at 3:32 PM
0 · Reply
Buddy44444444
Buddy44444444 Sep. 9 at 10:26 PM
$IBIO 👀
0 · Reply
Buddy44444444
Buddy44444444 Sep. 9 at 10:26 PM
0 · Reply
Buddy44444444
Buddy44444444 Sep. 9 at 10:26 PM
0 · Reply
Buddy44444444
Buddy44444444 Sep. 9 at 9:13 PM
$IBIO boy I wish we could play after hours seemed like that’s where all the excitement is
0 · Reply
Buddy44444444
Buddy44444444 Sep. 9 at 9:12 PM
$IBIO does it always go down when there’s talk about it when they have a Wells Fargo talk
1 · Reply
DSB1
DSB1 Sep. 9 at 4:50 PM
$IBIO October 1, iBio will deliver a presentation of the full IBIO-610 dataset at the European Association for the Study of Diabetes (EASD) Annual Meeting. EASD is one of the world’s leading scientific organizations focused on diabetes, obesity, metabolism, and related therapies. Its Annual Meeting is a major international medical conference where researchers, clinicians, pharmaceutical companies, and biotechnology companies present new clinical and preclinical research.
1 · Reply
Joelew22
Joelew22 Sep. 9 at 1:24 PM
0 · Reply
Buddy44444444
Buddy44444444 Sep. 9 at 12:30 PM
$IBIO positive chat
0 · Reply
Futtlappl
Futtlappl Sep. 9 at 12:25 PM
$IBIO good question so far! Someone can highlight us? thanks
0 · Reply
Latest News on IBIO
iBio, Inc. Proxy statement: Proxy filing

Sep 4, 2026, 8:00 AM EDT - 9 days ago

iBio, Inc. Proxy statement: Proxy filing


iBio, Inc. Annual report: Q4 2026

Aug 28, 2026, 7:00 AM EDT - 16 days ago

iBio, Inc. Annual report: Q4 2026


iBio, Inc. Earnings release: Q4 2026

Aug 28, 2026, 7:00 AM EDT - 16 days ago

iBio, Inc. Earnings release: Q4 2026


iBio, Inc. Proxy statement: Proxy filing

Aug 20, 2026, 8:00 AM EDT - 24 days ago

iBio, Inc. Proxy statement: Proxy filing


iBio appoints Molly Carr as chief medical officer

2026-08-04T13:15:57.000Z - 5 weeks ago

iBio appoints Molly Carr as chief medical officer

LLY


iBio announces new preclinical data from IBIO-610 study

2026-07-01T11:30:17.000Z - 2 months ago

iBio announces new preclinical data from IBIO-610 study


iBio initiated with an Outperform at Raymond James

2026-06-08T10:37:48.000Z - 3 months ago

iBio initiated with an Outperform at Raymond James


iBio to Participate in Upcoming Healthcare Investor Conferences

Jun 2, 2026, 4:01 PM EDT - 3 months ago

iBio to Participate in Upcoming Healthcare Investor Conferences


iBio doses first participant in IBIO-600 trial

2026-06-02T11:44:33.000Z - 3 months ago

iBio doses first participant in IBIO-600 trial


iBio, Inc. Slides: Corporate presentation

May 15, 2026, 7:00 AM EDT - 4 months ago

iBio, Inc. Slides: Corporate presentation


iBio reports Q3 EPS (7c), consensus (6c)

2026-05-12T21:36:01.000Z - 4 months ago

iBio reports Q3 EPS (7c), consensus (6c)


iBio, Inc. Earnings release: Q3 2026

May 12, 2026, 4:00 PM EDT - 4 months ago

iBio, Inc. Earnings release: Q3 2026


iBio, Inc. Quarterly report: Q3 2026

May 12, 2026, 4:00 PM EDT - 4 months ago

iBio, Inc. Quarterly report: Q3 2026


iBio, Inc. Transcript: Status update

Apr 8, 2026, 2:00 PM EDT - 5 months ago

iBio, Inc. Transcript: Status update


Biotech Alert: Searches spiking for these stocks today

2026-03-30T16:21:02.000Z - 5 months ago

Biotech Alert: Searches spiking for these stocks today

ACOG


iBio, Inc. Transcript: Study update

Mar 17, 2026, 4:00 PM EDT - 5 months ago

iBio, Inc. Transcript: Study update


iBio to provide update on cardiopulmonary program

2026-03-16T20:40:52.000Z - 6 months ago

iBio to provide update on cardiopulmonary program


iBio, Inc. Slides: Corporate presentation

Mar 9, 2026, 7:00 AM EDT - 6 months ago

iBio, Inc. Slides: Corporate presentation


iBio initiated with a Buy at JonesResearch

2026-03-02T21:34:02.000Z - 6 months ago

iBio initiated with a Buy at JonesResearch


iBio files $200M mixed securities shelf

2026-02-27T21:36:51.000Z - 6 months ago

iBio files $200M mixed securities shelf


Biotech Alert: Searches spiking for these stocks today

2026-02-27T16:00:56.000Z - 6 months ago

Biotech Alert: Searches spiking for these stocks today


iBio, Inc. Registration statement: Registration Filing

Feb 27, 2026, 7:00 AM EST - 6 months ago

iBio, Inc. Registration statement: Registration Filing


iBio to Participate in Upcoming Investor Conferences

Feb 24, 2026, 7:00 AM EST - 6 months ago

iBio to Participate in Upcoming Investor Conferences


iBio reports Q2 EPS (9c), consensus (6c)

2026-02-10T21:13:10.000Z - 7 months ago

iBio reports Q2 EPS (9c), consensus (6c)


iBio, Inc. Quarterly report: Q2 2026

Feb 10, 2026, 4:00 PM EST - 7 months ago

iBio, Inc. Quarterly report: Q2 2026


iBio, Inc. Earnings release: Q2 2026

Feb 10, 2026, 4:00 PM EST - 7 months ago

iBio, Inc. Earnings release: Q2 2026


iBio, Inc. Registration statement: Registration Filing

Jan 30, 2026, 7:00 AM EST - 7 months ago

iBio, Inc. Registration statement: Registration Filing


iBio prices 11.06M shares at $2.35 in private placement

2026-01-09T12:13:56.000Z - 8 months ago

iBio prices 11.06M shares at $2.35 in private placement


iBio Announces $26 Million Private Placement

Jan 9, 2026, 7:00 AM EST - 8 months ago

iBio Announces $26 Million Private Placement


Biotech Alert: Searches spiking for these stocks today

2026-01-08T17:16:04.000Z - 8 months ago

Biotech Alert: Searches spiking for these stocks today


iBio initiated with an Outperform at LifeSci Capital

2025-12-18T14:06:19.000Z - 8 months ago

iBio initiated with an Outperform at LifeSci Capital

ARWR WVE


iBio initiated with an Outperform at LifeSci Capital

2025-12-18T13:41:09.000Z - 8 months ago

iBio initiated with an Outperform at LifeSci Capital


Biotech Alert: Searches spiking for these stocks today

2025-12-11T16:45:34.000Z - 9 months ago

Biotech Alert: Searches spiking for these stocks today

CAMP


iBio, Inc. Slides: Corporate presentation

Nov 17, 2025, 7:00 AM EST - 10 months ago

iBio, Inc. Slides: Corporate presentation


iBio, Inc. Earnings release: Q1 2026

Nov 12, 2025, 4:00 PM EST - 10 months ago

iBio, Inc. Earnings release: Q1 2026


iBio, Inc. Quarterly report: Q1 2026

Nov 12, 2025, 4:00 PM EST - 10 months ago

iBio, Inc. Quarterly report: Q1 2026


iBio, Inc. Proxy statement: Proxy Filing

Oct 6, 2025, 8:00 AM EDT - 11 months ago

iBio, Inc. Proxy statement: Proxy Filing


iBio, Inc. Slides: Corporate Presentation

Sep 16, 2025, 7:00 AM EDT - 12 months ago

iBio, Inc. Slides: Corporate Presentation


iBio, Inc. Annual report: Q4 2025

Sep 5, 2025, 9:00 AM EDT - 1 year ago

iBio, Inc. Annual report: Q4 2025


iBio, Inc. Earnings release: Q4 2025

Sep 5, 2025, 9:00 AM EDT - 1 year ago

iBio, Inc. Earnings release: Q4 2025


iBio Announces Closing of $50 Million Public Offering

Aug 25, 2025, 7:00 AM EDT - 1 year ago

iBio Announces Closing of $50 Million Public Offering


iBio Announces Pricing of $50 Million Public Offering

Aug 19, 2025, 8:01 AM EDT - 1 year ago

iBio Announces Pricing of $50 Million Public Offering


iBio Announces Proposed Public Offering

Aug 18, 2025, 4:01 PM EDT - 1 year ago

iBio Announces Proposed Public Offering


iBio, Inc. Transcript: Study Update

Jun 24, 2025, 8:30 AM EDT - 1 year ago

iBio, Inc. Transcript: Study Update


iBio, Inc. Press release: Study Update

Jun 24, 2025, 8:30 AM EDT - 1 year ago

iBio, Inc. Press release: Study Update


iBio, Inc. Slides: Study Update

Jun 24, 2025, 8:30 AM EDT - 1 year ago

iBio, Inc. Slides: Study Update


iBio, Inc. Registration statement: Registration Filing

Jun 13, 2025, 8:00 AM EDT - 1 year ago

iBio, Inc. Registration statement: Registration Filing


iBio Reports Fiscal Third Quarter 2025 Financial Results

May 2, 2025, 8:00 AM EDT - 1 year ago

iBio Reports Fiscal Third Quarter 2025 Financial Results


iBio, Inc. Quarterly report: Q3 2025

May 2, 2025, 8:00 AM EDT - 1 year ago

iBio, Inc. Quarterly report: Q3 2025


iBio, Inc. Earnings release: Q3 2025

May 2, 2025, 8:00 AM EDT - 1 year ago

iBio, Inc. Earnings release: Q3 2025


iBio to Begin Trading on the Nasdaq Stock Exchange

Feb 19, 2025, 4:05 PM EST - 1 year ago

iBio to Begin Trading on the Nasdaq Stock Exchange


iBio Reports Fiscal Second Quarter 2025 Financial Results

Feb 10, 2025, 4:05 PM EST - 1 year ago

iBio Reports Fiscal Second Quarter 2025 Financial Results


iBio, Inc. Quarterly report: Q2 2025

Feb 10, 2025, 4:00 PM EST - 1 year ago

iBio, Inc. Quarterly report: Q2 2025


iBio, Inc. Earnings release: Q2 2025

Feb 10, 2025, 4:00 PM EST - 1 year ago

iBio, Inc. Earnings release: Q2 2025


iBio, Inc. Registration statement: Registration Filing

Jan 31, 2025, 7:00 AM EST - 1 year ago

iBio, Inc. Registration statement: Registration Filing


iBio Reports Fiscal First Quarter 2025 Financial Results

Nov 12, 2024, 4:05 PM EST - 1 year ago

iBio Reports Fiscal First Quarter 2025 Financial Results


iBio, Inc. Quarterly report: Q1 2025

Nov 12, 2024, 4:00 PM EST - 1 year ago

iBio, Inc. Quarterly report: Q1 2025


iBio, Inc. Earnings release: Q1 2025

Nov 12, 2024, 4:00 PM EST - 1 year ago

iBio, Inc. Earnings release: Q1 2025


iBio, Inc. Proxy statement: Proxy Filing

Oct 10, 2024, 8:00 AM EDT - 1 year ago

iBio, Inc. Proxy statement: Proxy Filing


iBio, Inc. Earnings release: Q4 2024

Sep 20, 2024, 4:00 PM EDT - 1 year ago

iBio, Inc. Earnings release: Q4 2024


iBio, Inc. Annual report: Q4 2024

Sep 20, 2024, 4:00 PM EDT - 1 year ago

iBio, Inc. Annual report: Q4 2024


iBio, Inc. Registration statement: Registration Filing

Jul 25, 2024, 8:00 AM EDT - 2 years ago

iBio, Inc. Registration statement: Registration Filing


iBio, Inc. Registration statement: Registration Filing

Jul 3, 2024, 8:00 AM EDT - 2 years ago

iBio, Inc. Registration statement: Registration Filing


iBio Closes Sale of Manufacturing Facility in Texas

Jun 3, 2024, 7:00 AM EDT - 2 years ago

iBio Closes Sale of Manufacturing Facility in Texas


iBio, Inc. Quarterly report: Q3 2024

May 14, 2024, 4:00 PM EDT - 2 years ago

iBio, Inc. Quarterly report: Q3 2024


iBio, Inc. Earnings release: Q3 2024

May 14, 2024, 4:00 PM EDT - 2 years ago

iBio, Inc. Earnings release: Q3 2024


iBio, Inc. Registration statement: Registration Filing

Apr 16, 2024, 8:00 AM EDT - 2 years ago

iBio, Inc. Registration statement: Registration Filing


iBio stock nearly tripled on Wednesday: here's why

Mar 27, 2024, 2:43 PM EDT - 2 years ago

iBio stock nearly tripled on Wednesday: here's why


iBio, Inc. Transcript: Collaboration

Mar 27, 2024, 8:30 AM EDT - 2 years ago

iBio, Inc. Transcript: Collaboration


iBio, Inc. Press release: Collaboration

Mar 27, 2024, 8:30 AM EDT - 2 years ago

iBio, Inc. Press release: Collaboration


iBio Announces $15.0 Million Private Placement

Mar 26, 2024, 7:35 PM EDT - 2 years ago

iBio Announces $15.0 Million Private Placement


iBio, Inc. Quarterly report: Q2 2024

Feb 9, 2024, 4:00 PM EST - 2 years ago

iBio, Inc. Quarterly report: Q2 2024


iBio, Inc. Earnings release: Q2 2024

Feb 9, 2024, 4:00 PM EST - 2 years ago

iBio, Inc. Earnings release: Q2 2024


iBio Announces Participation in 23rd Annual PepTalk Conference

Jan 16, 2024, 8:15 AM EST - 2 years ago

iBio Announces Participation in 23rd Annual PepTalk Conference


iBio Amends and Extends Maturity of Credit Agreement

Dec 26, 2023, 7:15 AM EST - 2 years ago

iBio Amends and Extends Maturity of Credit Agreement


iBio, Inc. Announces Pricing of $4.5 Million Public Offering

Dec 5, 2023, 8:00 AM EST - 2 years ago

iBio, Inc. Announces Pricing of $4.5 Million Public Offering


iBio, Inc. Registration statement: Registration Filing

Nov 30, 2023, 7:00 AM EST - 2 years ago

iBio, Inc. Registration statement: Registration Filing


iBio Announces Reverse Stock Split

Nov 27, 2023, 5:20 PM EST - 2 years ago

iBio Announces Reverse Stock Split


iBio, Inc. Quarterly report: Q1 2024

Nov 14, 2023, 7:00 AM EST - 2 years ago

iBio, Inc. Quarterly report: Q1 2024


iBio, Inc. Earnings release: Q1 2024

Nov 14, 2023, 7:00 AM EST - 2 years ago

iBio, Inc. Earnings release: Q1 2024


iBio, Inc. Registration statement: Registration Filing

Oct 27, 2023, 8:00 AM EDT - 2 years ago

iBio, Inc. Registration statement: Registration Filing


iBio, Inc. Proxy statement: Proxy Filing

Oct 26, 2023, 8:00 AM EDT - 2 years ago

iBio, Inc. Proxy statement: Proxy Filing


iBio, Inc. Proxy statement: Proxy Filing

Oct 16, 2023, 8:00 AM EDT - 2 years ago

iBio, Inc. Proxy statement: Proxy Filing


iBio Explains Recent Filing of Registration Statement

Oct 2, 2023, 6:45 AM EDT - 2 years ago

iBio Explains Recent Filing of Registration Statement


iBio Announces Filing of 2023 Annual Report on SEC Form 10-K

Sep 27, 2023, 4:19 PM EDT - 2 years ago

iBio Announces Filing of 2023 Annual Report on SEC Form 10-K


iBio, Inc. Annual report: Q4 2023

Sep 27, 2023, 4:00 PM EDT - 2 years ago

iBio, Inc. Annual report: Q4 2023


iBio Announces Amendment to Credit Agreement with Woodforest

Sep 21, 2023, 4:05 PM EDT - 2 years ago

iBio Announces Amendment to Credit Agreement with Woodforest


Buddy44444444
Buddy44444444 Sep. 11 at 3:32 PM
0 · Reply
Buddy44444444
Buddy44444444 Sep. 9 at 10:26 PM
$IBIO 👀
0 · Reply
Buddy44444444
Buddy44444444 Sep. 9 at 10:26 PM
0 · Reply
Buddy44444444
Buddy44444444 Sep. 9 at 10:26 PM
0 · Reply
Buddy44444444
Buddy44444444 Sep. 9 at 9:13 PM
$IBIO boy I wish we could play after hours seemed like that’s where all the excitement is
0 · Reply
Buddy44444444
Buddy44444444 Sep. 9 at 9:12 PM
$IBIO does it always go down when there’s talk about it when they have a Wells Fargo talk
1 · Reply
DSB1
DSB1 Sep. 9 at 4:50 PM
$IBIO October 1, iBio will deliver a presentation of the full IBIO-610 dataset at the European Association for the Study of Diabetes (EASD) Annual Meeting. EASD is one of the world’s leading scientific organizations focused on diabetes, obesity, metabolism, and related therapies. Its Annual Meeting is a major international medical conference where researchers, clinicians, pharmaceutical companies, and biotechnology companies present new clinical and preclinical research.
1 · Reply
Joelew22
Joelew22 Sep. 9 at 1:24 PM
0 · Reply
Buddy44444444
Buddy44444444 Sep. 9 at 12:30 PM
$IBIO positive chat
0 · Reply
Futtlappl
Futtlappl Sep. 9 at 12:25 PM
$IBIO good question so far! Someone can highlight us? thanks
0 · Reply
Self_Made_Man
Self_Made_Man Sep. 9 at 12:14 PM
$IBIO Why is it a vote to add 500,000,000 more shares?
0 · Reply
DSB1
DSB1 Sep. 9 at 2:51 AM
$IBIO A. IBIO-600 SAD dosing completed — safety/PK data Q1 2027. B. IBIO-610 moving toward human trials in early 2027. C. 610 potentially supports quarterly/semiannual dosing. D. Management wants to “own” the Activin E space with multiple programs. E. Clear strategy to advance assets and pursue partnerships before expensive late-stage trials. F. Building the clinical/regulatory team to take programs through Phase II. G. Multiple cardiometabolic programs = multiple shots on goal. H. Brenner sounded confident and focused on execution, not hype. Overall: pipeline is advancing, timelines are becoming clearer, and the partnership strategy is now much more explicit.
0 · Reply
Retail_Lives_Matter
Retail_Lives_Matter Sep. 8 at 10:05 PM
$IBIO I missed the “big” fireside chat today, super quiet around here, nothing interesting???
0 · Reply
6Wallstreet9
6Wallstreet9 Sep. 8 at 7:27 PM
$IBIO Fireside Chat Today! “Reduce fat while preserving lean muscle mass.” 💡✨️
1 · Reply
TortillaDePatata
TortillaDePatata Sep. 8 at 1:32 PM
$IBIO Is Novo Nordisk contacting IBIO?
0 · Reply
DSB1
DSB1 Sep. 8 at 1:20 PM
$IBIO If Brenner announces encouraging news tonight. 🤑
0 · Reply
Buddy44444444
Buddy44444444 Sep. 7 at 9:53 PM
$IBIO fire side meeting tomorrow 4:30 after closing you’ll be big news
0 · Reply
Buddy44444444
Buddy44444444 Sep. 7 at 9:51 PM
$IBIO sept 8
0 · Reply
Floridaorange
Floridaorange Sep. 4 at 7:44 PM
$IBIO investors: put NGEN on your radar. • Registrational Phase 3 for chronic spinal cord injury • CONNECT: 3.3-point placebo-adjusted GRASSP-M improvement • 10/10 treated showed grip-strength improvement vs 1/10 placebo • Supported by electrophysiology + biomechanics • FDA Fast Track • Decades of CNS-repair science If RESTORE reproduces even a fraction of CONNECT, today’s valuation could look very different.
0 · Reply
donbuckets7
donbuckets7 Sep. 4 at 7:17 PM
0 · Reply
Calida760
Calida760 Sep. 4 at 5:31 PM
$IBIO look up RARE good entry for rebound, oversold with near term catalyst in 2wks. Fda approval
0 · Reply
crs1
crs1 Sep. 4 at 1:42 PM
$IBIO not a company because it has never and will not create anything. this one is the absolute definition of a bio tech scam. Bio farming to this latest AI BS. Don't risk your money here.
3 · Reply